fda glp-1 news november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounded GLP-1s: Why doctors worry

This is a pivotal moment for the food industry. Noting that 12% of the US population has tried the drugs, with 6% actively using them, Harold Schmitz at VC firm The March Group said the Ozempic era is helping to rejuvenate the foodtech space, which is now very much alive. Courtney McHugh, chief commercial officer at Amplifye, a UC Davis spinout with an enzyme that helps the body digest protein more effectively, added: Theres an entire secondary market that can come from any breakthrough technology. This is only the first generation of GLP-1 drugs and therefore the first generation of secondary markets, observed McHugh, who said GLP-1 drugs are driving interest in products that solve for energy levels, nutrient deficiencies, and gut issues. They are also prompting renewed interest in protein quality as well as quantity, she claimed

Rapid metabolic and hormonal changes accompanying significant weight loss may temporarily affect sexual desire

doi:10.1056/NEJMoa1109400 69

Biochemical analysis of uterine and ovarian tissues All the uterine and ovarian tissues were weighed and homogenized on ice with 2 ml of the relevant buffer

Following an overnight fast, the patient consumes a standardized, radiotracer-bound, low-fat meal within 10 minutes of this test

Cannabis has not been analyzed or approved by the Food and Drug Administration (FDA)